Article By: SecretCaps
Friday, February 6, 2015 10:03 AM EDT
Immucell Corporation is a completely unknown biotech stock; this research report is the first coverage ever, including an interview with the CEO. Shares are currently trading far below fair value, but that won't last long, as I expect the share price to double quickly.
In this article: ICCC